Strategies to incorporate left atrial appendage occlusion into clinical practice

Journal of the American College of Cardiology

Volumn 65, Issue 21, 2015, Pages 2337-2344

  Alli, Oluseun ^a   Asirvatham, Samuel ^b   Holmes, David R ^b  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

anticoagulant agent(s); atrial fibrillation; stroke prevention; thromboembolism

Indexed keywords

ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CARDIOVASCULAR THERAPEUTIC DEVICE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DEVICE SAFETY; FOLLOW UP; HEALTH CARE UTILIZATION; HEALTH PERSONNEL ATTITUDE; HEART LEFT ATRIAL APPENDAGE OCCLUDER; HEART LEFT ATRIAL APPENDAGE OCCLUSION; HUMAN; INFORMATION PROCESSING; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MEDICAL EDUCATION; PATIENT REFERRAL; PRIORITY JOURNAL; PROGRAM EVALUATION; REVIEW; TEAMWORK; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; COMPLICATION; HEART ATRIUM; PATIENT SELECTION; SEPTAL OCCLUDER;

ATRIAL FIBRILLATION; HEART ATRIA; HUMANS; PATIENT SELECTION; SEPTAL OCCLUDER DEVICE; THROMBOEMBOLISM;

EID: 84930038993     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.03.564     Document Type: Review

References (30)

1. A.S. Go, E.M. Hylek, and K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375
2. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
3. R.G. Hart, O. Benavente, and R. McBride Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 131 1999 492 501
4. D.R. Holmes, V.Y. Reddy, Z.G. Turi for the PROTECT AF Investigators Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 2009 534 542
5. V.Y. Reddy, D. Holmes, and S.K. Doshi Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry Circulation 123 2011 417 424
6. K. Bartus, F.T. Han, and J. Bednarek Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience J Am Coll Cardiol 62 2013 108 118
7. D.R. Holmes Jr., S. Kar, and M.J. Price Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure Device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial J Am Coll Cardiol 64 2014 1 12
8. V.Y. Reddy, S.K. Doshi, H. Sievert for the PROTECT AF Investigators Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial Circulation 127 2013 720 729
9. Boston Scientific. Boston Scientific Receives FDA Approval For WATCHMAN Left Atrial Appendage Closure Device. March 13, 2015. Available at: http://www.multivu.com/players/English/7223452-boston-scientific-watchman-fda-approval/. Accessed April 1, 2015.
10. Boston Scientific. WATCHMAN Left Atrial Appendage Closure Device With Delivery System. 2014. Available at: http://www.accessdata.fda.gov/cdrh-docs/pdf13/P130013d.pdf. Accessed April 1, 2015.
11. M. Sudlow, R. Thomson, and B. Thwaites Prevalence of atrial fibrillation and eligibility for anticoagulants in the community Lancet 352 1998 1167 1171
12. L.M. Brass, H.M. Krumholz, and J.M. Scinto Warfarin use among patients with atrial fibrillation Stroke 28 1997 2382 2389
13. A.S. Go, E.M. Hylek, and L.H. Borowsky Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study Ann Intern Med 131 1999 927 934
14. Y.L. Bayard, H. Omran, and P. Neuzil PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study EuroIntervention 6 2010 220 226
15. V.Y. Reddy, S. Mobius-Winkler, and M.A. Miller Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology) J Am Coll Cardiol 61 2013 2551 2556
16. G.Y. Lip, L. Frison, and J.L. Halperin Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score J Am Coll Cardiol 57 2011 173 180
17. G.Y. Lip, F. Andreotti, and L. Fauchier Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis Europace 13 2011 723 746
18. M.J. Swaans, M.C. Post, and B.J. Rensing Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study J Am Heart Assoc 1 2012 e002212
19. A. Schade, S. Kerber, and K. Hamm Two in a single procedure: combined approach for MitraClip implantation and left atrial appendage occlusion using the Watchman device J Invasive Cardiol 26 2014 E32 E34
20. A.J. Camm, G.Y. Lip, R. De Caterina for the ESC Committee for Practice Guidelines-CPG; Document Reviewers 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Association Europace 14 2012 1385 1413
21. B. Meier, Y. Blaauw, and A.A. Khattab EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion Europace 16 2014 1397 1416
22. B. Meier, I. Palacios, and S. Windecker Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation Catheter Cardiovasc Interv 60 2003 417 422
23. J.W. Park, A. Bethencourt, and H. Sievert Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience Catheter Cardiovasc Interv 77 2011 700 706
24. Y.Y. Lam, G.W. Yip, and C.M. Yu Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience Catheter Cardiovasc Interv 79 2012 794 800
25. A. Tzikas, S. Shakir, and S. Gafoor Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug EuroIntervention 2015 Jan 22 [E-pub ahead of print]
26. A.J. Camm, A. Colombo, and G. Corbucci Left atrial appendage closure: a new technique for clinical practice Heart Rhythm 11 2014 514 521
27. F.T. Han, K. Bartus, and D. Lakkireddy The effects of LAA ligation on LAA electrical activity Heart Rhythm 11 2014 864 870
28. M.J. Price, D.N. Gibson, and S.J. Yakubov Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. Transcatheter LAA Ligation Consortium J Am Coll Cardiol 64 2014 565 572
29. R. Whitlock, J. Healey, and J. Vincent Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III Ann Cardiothorac Surg 3 2014 45 54
30. A.P. Kappetein, S.J. Head, and P. Genereux Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document J Am Coll Cardiol 60 2012 1438 1454